[Treatment of Takayasu's disease with low-dose methotrexate. Apropos of a case].
Persistent evidence of inflammation at the occlusive phase of Takayasu's arteritis is of adverse prognostic significance. Low-dose weekly methotrexate therapy given in combination with a corticosteroid may be effective in such patients. We report a personal case which supports the data obtained by Fauci and coworkers, as well as the conclusions of the other two similar case-reports in the literature.
Service de Rhumatologie, CHU Poitiers.
M
M
Alcalay
F
F
Debiais
I
I
Chartier
D
D
Bontoux
D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013625:Takayasu Arteritis / Q000188:drug therapy; D013997:Time Factors
D011241:Prednisone; D008727:Methotrexate
Traitement de la maladie de Takayasu par le méthotrexate à faible dose. A propos d'un cas.